NEW Enterprise Associates 13 L.P., 10% Owner at Omthera Pharmaceuticals, Inc. (OMTH), sold 196 shares at $8.00 ($2K) on 2013-04-16, disclosed to the SEC on 2013-04-17.
Open-market sale of $2k OMTH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| TSRO | BUY | 2018-03-06 | $6.7M | — | Filing → |
| RARX | BUY | 2016-10-31 | $4.4M | — | Filing → |
| RARX | SELL | 2016-10-31 | $6K | — | Filing → |